CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy (Q46192339)

20 December 2017

title

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy (English)

1 reference

20 December 2017

1 reference

1 reference

acute myeloid leukemia

1 reference

D Gallardo

15

0 references

Mar Tormo

object named as

M Tormo

4

0 references

Josep Nomdedeu

object named as

J Nomdedeu

5

0 references

author name string

A Pérez-García

1

1 reference

20 December 2017

S Brunet

2

1 reference

20 December 2017

J J Berlanga

3

1 reference

20 December 2017

R Guardia

6

1 reference

20 December 2017

J M Ribera

7

1 reference

20 December 2017

I Heras

8

1 reference

20 December 2017

A Llorente

9

1 reference

20 December 2017

M Hoyos

10

1 reference

20 December 2017

J Esteve

11

1 reference

20 December 2017

J Besalduch

12

1 reference

20 December 2017

J Bueno

13

1 reference

20 December 2017

J Sierra

14

1 reference

20 December 2017

Grupo cooperativo para el estudio y tratamiento de las leucemias agudas

16

1 reference

20 December 2017

publication date

18 December 2008

1 reference

20 December 2017

published in

Leukemia

1 reference

20 December 2017

volume

23

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

486-491

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2008.339

exact match

0 references

cites work

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

A molecular perspective of CTLA-4 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

inferred from DOI database lookup

7 January 2021

based on heuristic

Differential inhibition of autoreactive memory- and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.339

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2008.339

1 reference

20 December 2017

PubMed ID

19092854

1 reference

20 December 2017